Chase Coleman’s Teladoc Health TDOC Stock Holding History

Chase Coleman’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-235,558	Closed	-$8.21M	–	66
2017 Q4	$8.21M	Sell	235,558 -1,557,241	-87%	-$51.7M	0.06%	41
2017 Q3	$59.4M	Sell	1,792,799 -2,299,393	-56%	-$75.4M	0.4%	31
2017 Q2	$142M	Sell	4,092,192 -806,600	-16%	-$23.5M	1.23%	16
2017 Q1	$122M	Buy	+4,898,792	New	+$102M	1.23%	16

Other funds holding TDOC

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Chase Coleman's TDOC Position: Q1 2018 in Review

Chase Coleman sold out of Teladoc Health (TDOC) in Q1 2018, closing a stake of 235,558 shares — an estimated $8.21M sold.

Chase Coleman first reported a position in TDOC in Q1 2017 and held it in 4 quarters. The position peaked at $142M in Q2 2017. 230 funds tracked by Wall St. Rank hold TDOC as of Q1 2018.

Chase Coleman reported no remaining Teladoc Health position as of Q1 2018 after selling out during the quarter.
Chase Coleman sold 235,558 Teladoc Health shares in Q1 2018, an estimated $8.21M.
Chase Coleman first reported a position in Teladoc Health in Q1 2017 and held it in 4 quarters.
Chase Coleman's Teladoc Health position peaked at $142M in Q2 2017.
230 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2018.

Based on Tiger Global Management's 13F filing for Q1 2018, filed 15 May 2018.